• Citer

CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis.

par Teixeira-Clerc, Fatima;Julien, Boris;Grenard, Pascale;Tran Van Nhieu, Jeanne;Deveaux, Vanessa;Li, Liying;Serriere-Lanneau, Valérie;Ledent, Catherine ;Mallat, Ariane;Lotersztajn, Sophie
Référence Nature medicine, 12, 6, page (671-676)
Publication Publié, 2006-06

Article révisé par les pairs

• Détails
• Contenu

Titre:	CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis.
Auteur:	Teixeira-Clerc, Fatima; Julien, Boris; Grenard, Pascale; Tran Van Nhieu, Jeanne; Deveaux, Vanessa; Li, Liying; Serriere-Lanneau, Valérie; Ledent, Catherine; Mallat, Ariane; Lotersztajn, Sophie
Informations sur la publication:	Nature medicine, 12, 6, page (671-676)
Statut de publication:	Publié, 2006-06
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Animals
	Disease Progression
	Endocannabinoids -- metabolism
	Female
	Humans
	Liver -- metabolism
	Liver -- pathology
	Liver Cirrhosis -- pathology
	Liver Cirrhosis -- therapy
	Male
	Mice
	Mice, Inbred C57BL
	Mice, Knockout
	Piperidines -- metabolism
	Piperidines -- therapeutic use
	Pyrazoles -- metabolism
	Pyrazoles -- therapeutic use
	Receptor, Cannabinoid, CB1 -- antagonists & inhibitors
	Receptor, Cannabinoid, CB1 -- genetics
	Receptor, Cannabinoid, CB1 -- metabolism
	Receptor, Cannabinoid, CB2 -- metabolism
	Retrospective Studies
	Transforming Growth Factor beta -- metabolism
	Transforming Growth Factor beta1
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:1078-8956
	info:doi/10.1038/nm1421
	info:pii/nm1421
	info:scp/33745003240
	info:pmid/16715087